Antiseptic gargle in COVID-19

Not Applicable

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00024028
• Lead Sponsor: niversitätsmedizin Rostock

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-11
• Study Completion: 2021-04-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 152

Inclusion Criteria

Hospital admission at University Hospital Rostock and positive SARS-CoV-2 PCR (specimen from oropharyngeal swab), consent to participate

Exclusion Criteria

Pregnancy, past or current alcohol dependence, intolerance of chlorhexidine

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time from initial positive SARS-CoV-2 PCR (from nasopharyngeal swab) until first of two negative specimen (specimens are taken every 2-3 days).

Secondary Outcome Measures

Name	Time	Method
Course of oxygen saturation (pulse oximetry), oxygen flow through nasal cannula, invasive or non-invasive ventilation, admission to intensive care unit, time until symptom-free, death, known secondary infections by study participant